Dr. Sharmistha Ghosh-Janjigian serves as a Program Director for the Cancer Biomarkers Research Group. Her portfolio includes a variety of scientific programs focused on risk assessment, detection, diagnosis, and prognosis of early cancer. Dr. Ghosh-Janjigian provides scientific and programmatic leadership to the Pancreatic Cancer Detection Consortium (PCDC). In addition, she is involved in the activities of the following programs: Early Detection Research Network (EDRN), Human Tumor Atlas Network (HTAN), Synthetic Biology and Cancer, Translational and Basic Science Research in Early Lesions (TBEL), Cancer Grand Challenges (CGC), and Consortium for the Study of Chronic Pancreatitis, Diabetes and Pancreatic Cancer (CPDPC). Dr. Ghosh-Janjigian also serves on several trans-NCI and trans-NIH committees.

Dr. Ghosh-Janjigian earned her undergraduate and graduate degrees from Presidency College/University of Calcutta and Jawaharlal Nehru University in India and conducted postgraduate research at the Beth Israel Deaconess Medical Center/Harvard Medical School in Boston. Prior to joining the Division of Cancer Prevention in 2013, Dr. Ghosh-Janjigian served as a Scientific Editor for Biochimica et Biophysica Acta and a Senior Editor for Journal of the National Cancer Institute.